Skip to main content
. Author manuscript; available in PMC: 2019 Dec 7.
Published in final edited form as: Prostate. 2018 Jun 7:10.1002/pros.23662. doi: 10.1002/pros.23662

Table 2.2.

Number of Patients with Treatment-Related AEs according to cabozantinib dose level

cabozantinib dose level TOTAL
cabozantinib 20mg,
abiraterone 1000mg
cabozantinib 40mg,
abiraterone 1000mg
cabozantinib 60mg,
abiraterone 1000mg
N % N % N % N %
Maximum Grade 3 27.3 1 8.3 - - 4 15.4
1
2 3 27.3 3 25.0 1 33.3 7 26.9
3 5 45.5 8 66.7 2 66.7 15 57.7
Total 11 100.0 12 100.0 3 100.0 26 100.0
*

maximum grade consolidates reports of all AEs of same type for a patient.